Orexo

18,86 SEK

-0,32%

Mindre end 1K følgere

ORX

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Værdiansættelse

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Orexo

P/E

Medianen 2019-2025

EV/S

Medianen 2019-2024

EV/EBIT

Medianen 2019-2024

P/B

Medianen 2019-2025

 
2019202020212022202320242025
Aktiekurs (SEK)62,8050,0034,5018,8615,4617,5030,10
Aktier34,634,634,334,434,434,534,7
Markedsværdi2.174,21.731,11.184,5648,2532,6603,81.044,6
Enterprise value1.647,01.450,31.230,9836,0835,4956,5-
EV/S1,92,22,21,31,31,6-
EV/EBITDA6,176,3neg.neg.neg.40,9-
EV/EBIT7,1neg.neg.neg.neg.neg.-
P/E9,9neg.neg.neg.neg.neg.1,6
P/B3,083,103,393,349,04-4,782,13
P/S2,62,62,11,00,81,040,2
Udbytteprocent0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %
Equity ratio47,1 %45,3 %27,4 %17,5 %7,5 %-21,2 %37,7 %
Gearing ratio48,7 %48,7 %157,5 %278,3 %804,4 %-376,9 %100,2 %